- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
156 Cards in this Set
- Front
- Back
|
Which drugs should be given at even intervals apart (e.g. Q12 rather than BID)unless otherwise ordered?
|
Antibiotics, psychotropics, and cardiac drugs
|
|
CARDIAC GLYCOSIDE:
Digoxin (Lanoxin) Indications: |
CHF, A-fib or Supraventricular arrhythmias.
|
|
Digoxin (Lanoxin)
Three main actions |
to increase myocardial contractility, decrease SA node activity and Decrease Cardiac conduction rates.
|
|
Digoxin (Lanoxin)
Important adverse effects: |
Bradycardia, arrhythmias, yellow-green halos around visual images, nausea, anorexia, headache.
|
|
Digoxin (Lanoxin)
Notes: |
-may require a loading dose to achieve a therapeutic effect.
-Monitor serum levels as window between therapeutic and toxic levels is narrow. -Monitor Apical Pulse for one minute prior to administration. Hold for pulse< 60 or > 120 and notify MD. -Hypomagnesemia, Hypokalemia and Hypercalcemia contribute to toxicity. |
|
CALCIUM CHANNEL BLOCKERS:
|
Diltiazem (Cardizem)
Nicardipene (Cardene) Nifedipine (Procardia) Verapamil (Calan) Amlodipine (Norvasc) |
|
CALCIUM CHANNEL BLOCKERS:
Action |
Decreased influx of calcium ions into calcium channels of myocardium and peripheral vasculature.
|
|
CALCIUM CHANNEL BLOCKERS:
Indication |
HTN, Angina.
|
|
CALCIUM CHANNEL BLOCKERS:
Important A/E |
Headache, fatigue, dizziness, edema, arrhythmias, hypotension, CHF. Bradycardia for Verapamil and Diltiazem.
|
|
BETA BLOCKERS:
|
Nadolol (Corgard)
Propranolol (Inderal) Metoprolol (Lopressor) Atenolol (Tenormin) Metoprolol Succinate (Toprol XL) Carvedilol (Coreg) |
|
BETA BLOCKERS:
Actions |
Blocks beta-adrenergic receptor stimulation
|
|
BETA BLOCKERS:
Indications |
HTN, Tachycardia,CHF, angina.
|
|
BETA BLOCKERS:
Important A/E |
Bradycardia, CHF, Hypotension, worsened peripheral vascular disease, bronchospasms, depression, heart block, fatigue.
|
|
BETA BLOCKERS:
Note: |
-can mask symptoms of hypoglycemia.
|
|
ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS
|
Enalapril (Vasotec)
Lisinopril (Prinivil or Zestril) Ramopril (Altace) Quinapril (Accupril) |
|
(ACE) INHIBITORS
Actions |
Inhibit conversion of Angiotensin I to Angiotensin II. Results in decreased vasoconstriction and decreased aldosterone secretion.
|
|
(ACE) INHIBITORS
Indications |
HTN, CHF.
|
|
(ACE) INHIBITORS
Important A/E |
Impaired renal function, neutropenia, Headache, Hypotension, Cough, Angioedema, Hyperkalemia,
Lightheadedness. |
|
(ACE) INHIBITORS
Note: |
-Severe first dose hypotension can occur warn patient.
|
|
Angiotensin Receptor Blockers (ARBs)
|
Valsartan (Diovan)
Losartan (Cozaar) Candesartan (Atacand) |
|
Angiotensin Receptor Blockers (ARBs)
Action |
Block angiotensin II receptors resulting in decreased vasoconstriction and decreased aldosterone secretion.
|
|
Angiotensin Receptor Blockers (ARBs)
Indications & A/E |
same as ACE inhibitors except lower incidence of cough and angioedema.
|
|
SALICYLATES:
Aspirin Action |
decreases platelet aggregation. Centrally acting antipyretic, analgesic and antinflammatory.
|
|
SALICYLATES:
Aspirin Indications |
Pain, fever, inflammation, prophylaxis of cardiovascular disease.
|
|
SALICYLATES:
Aspirin Important A/E |
Prolonged bleeding time, Tinnitus, Abnormal Liver Functions, Worsened Asthma, Ulcers, GI Bleed.
|
|
NON-STEROIDAL ANTIIMFLAMMATORY DRUGS (NSAIDS):
|
Diclofenac Sodium (Voltaren) Ketorolac Tromethamine (Toradol)
Flurbiprofen (Ansaid) Sulindac (Clinoril) Ibuprofen (Motrin) Naproxen Sodium (Naprosyn) Indomethacin (Indocin) Piroxican (Feldene) Nabumetone (Relafen) |
|
(NSAIDS):
Action |
Decrease pain and inflammation through inhibition of prostaglandin.
|
|
(NSAIDS):
Indications |
Musculoskeletal Pain, Arthritis, Headache, Mild to Moderate Pain.
|
|
(NSAIDS):
Important A/E |
Abdominal Pain, GI Bleed, Renal Toxicity, Elevated liver Enzymes, Worsened Bronchospasms, Fluid Retention, Hypertension.
|
|
COX-2 Inhibitor
|
Celecoxib (Celebrex) Possible association with MI
(Similar to NSAIDS but less incidence of GI Bleed or Ulcers) |
|
BENZODIAZIPINES
|
Indicated for Insomnia:
Flurazepam (Dalmane) Temazepam (Restoril) Zolpidem (Ambien) Alprazolam (Xanax) Diazepam (Valium) Lorazepam (Ativan) Chlordiazepoxide (Librium) Clonazepam (Klonopin) |
|
Zolpidem (Ambien)
|
has shorter half-life less AM “hangover” less tendency for tolerance or rebound insomnia.
|
|
BENZODIAZIPINES
Action |
Enhances GABA a CNS depressant neurotransmitter.
|
|
BENZODIAZIPINES
Indications |
Anxiety, Muscle relaxants, Anticonvulsants, Alcohol Withdrawal.
|
|
BENZODIAZIPINES
Important A/E |
Drowsiness, Lethargy, Ataxia, Hypotension, Dry Mouth, Addiction.
|
|
BENZODIAZIPINES
Notes: |
-Do not withdraw abruptly.
-The elderly are vulnerable to accumulation and toxicity. |
|
Antidepressants
Selective serotonin re-uptake inhibitors (SSRIs) |
Fluoxetine (Prozac)
Paroxetine (Paxil) Setraline(Zoloft) Citalopram (Celexa) Escitalopram (Lexapro) |
|
(SSRIs)
Action |
Decreases re-uptake of Serotonin a neurotransmitter.
|
|
(SSRIs)
Indication |
Depression, Anxiety
|
|
(SSRIs)
A/E |
Tremors, anxiety, insomnia, nausea, anorexia, diarrhea, constipation, increased appetite, weight loss, seizures
|
|
(SSRIs)
Notes: |
Cannot be given within 14 days of administration of an MAO inhibitor: can trigger Hypertensive crisis. Assess for suicide risk
|
|
Combined SSRI/Neurepinephrine re-uptake inhibitors
|
Duloxetine (Cymbalta)
Venlafaxine (Effexor) |
|
Combined SSRI/Neurepinephrine re-uptake inhibitors
Actions |
Inhibits re-uptake of Serotonin and Neurepinephrine
|
|
Combined SSRI/Neurepinephrine re-uptake inhibitors
Indications |
Depression and Anxiety
|
|
Combined SSRI/Neurepinephrine re-uptake inhibitors
A/E |
Same as SSRIs plus increased BP
|
|
ANTICONVULSANTS
CARBAMAZIPINE (TEGRETOL): Indications |
Anticonvulsant, Affective disorders.
|
|
ANTICONVULSANTS
CARBAMAZIPINE (TEGRETOL): Important A/E |
Aplastic Anemia, Agranulocytosis, Thrombocytopenia, Dizziness, Sedation, GI Distress.
|
|
ANTICONVULSANTS
CARBAMAZIPINE (TEGRETOL): Notes |
-Monitor serum blood levels.
-Monitor CBC. |
|
ANTICONVULSANTS
PHENYTOIN (DILANTIN): Indications |
Anticonvulsant, Antiarrthymic.
|
|
ANTICONVULSANTS
PHENYTOIN (DILANTIN): Action |
Slows sodium channels.
|
|
ANTICONVULSANTS
PHENYTOIN (DILANTIN): Important A/E |
Pancytopenia, Megoblastic Anemia, Ataxia, Slurred Speech, Confusion, Arrthymias, Hypotension, Gingival Hyperplasia, Lupus Erthymatosous.
|
|
ANTICONVULSANTS
PHENYTOIN (DILANTIN): Notes: |
-Monitor serum blood levels, CBC, B12, and Folic acid Levels.
|
|
ANTICONVULSANTS
Gabapentin (Neurontin): Indications |
Anticonvulsant, Neuropathic pain, Agitation
|
|
ANTICONVULSANTS
Gabapentin (Neurontin): Important A/E |
Fatigue, somnolence, dizziness, ataxia, peripheral edema, nausea, vomiting, constipation, decreased WBC count.
|
|
ANTICONVULSANTS
Gabapentin (Neurontin): Notes: |
-withdrawal slowly if discontinued,
-can cause false positive for urine protein. |
|
ANTICONVULSANTS
Levetiracetam (Keppra) Indications |
Anticonvulsant
|
|
ANTICONVULSANTS
Levetiracetam (Keppra) Important A/E |
Fatigue, Somnolence, Ataxia, Dizziness, Bone Marrow Depression, Psychosis, Suicidal Behavior
|
|
NEUROLEPTICS
|
Haloperidol (Haldol)
Thioridazine (Mellaril) Thiothixene (Navane) Atypicals: Olanzapine (Zyprexa) Risperidone (Risperdal) Quetiapine (Seroquel) |
|
NEUROLEPTICS
Indications |
Psychosis, Agitation.
|
|
NEUROLEPTICS
Important A/E |
Extrapyramidal symptoms (Parkinson like rigidity and tremors)., Tardive Dyskinesia, Neuroleptic Malignant Syndrome (High Fever, Tachycardia, Tachypnea, Diaphoresis, rare but often fatal)., Sedation, Confusion, Constipation, Urinary Retention, Dry Mouth, orthostatic hypotension.
|
|
NEUROLEPTICS
Notes |
-Haldol and Navane have a high rate of EPS but a lower rate of sedation.
-Mellaril has a low incidence of EPS but a high rate of sedation. -Atypicals cause less EPS but tend to cause weight gain. |
|
BRONCHODILATORS
|
METAPROTERAL (ALUPENT)(short acting)
ALBUTEROL (PROVENTIL) (short acting) Salmeterol (Serevent) (long acting) Levalbuterol (Xopenex) (Short Acting) |
|
BRONCHODILATORS
Indication |
Asthma, Bronchospasm.
|
|
BRONCHODILATORS
Action |
Work by increasing action of sympathetic nervous system at Beta receptors.
|
|
BRONCHODILATORS
Important A/E |
Tremors, Agitation, Tachycardia, HTN, Palpitations.
|
|
BRONCHODILATORS
Notes: |
-Can be given by MDI(Metered Dose Inhaler) or Nebulization,
-Effective for routine or PRN use. -Teach proper use of inhaler. |
|
IPRATROPIUM BROMIDE (ATROVENT)
Indication |
Maintenance treatment of bronchospasms associated with COPD.
|
|
IPRATROPIUM BROMIDE (ATROVENT)
Action |
Works by inhibition of the Parasympathetic Nervous System.
|
|
IPRATROPIUM BROMIDE (ATROVENT)
Important A/E |
Nervousness, Dizziness, palpitations, tachycardia, cough
|
|
IPRATROPIUM BROMIDE (ATROVENT)
Notes |
-Not appropriate for emergency use.
-Teach proper use of MDI. |
|
THEOPHYLLINE (THEO-DUR)
Indications |
Prophylaxis and symptomatic relief of bronchospasm of Asthma or COPD.
|
|
THEOPHYLLINE (THEO-DUR)
Important A/E |
Restlessness, Dizziness, Seizures, Headache, Tachycardia, Palpitations, Hypotension, Nausea and Vomiting.
|
|
THEOPHYLLINE (THEO-DUR)
Notes: |
-Monitor serum blood levels.
|
|
INHALED STEROID:
|
BECLOMETHASONE (BECLOVENT, VANCERIL)
Triamcinolone (AZMACORT) Fluticasone (Flovent) |
|
INHALED STEROID:
Actions |
Decrease airway inflammatory response with topical steroid.
|
|
INHALED STEROID:
Indications |
Bronchospastic disease not responsive to Bronchodilators.
|
|
INHALED STEROID:
Important A/E |
Hoarseness, Fungal Infections of Mouth and Throat.
|
|
INHALED STEROID:
Notes |
-Not for Acute use.
-Instruct patient to rinse mouth after use to prevent candidiasis. -Administer after Bronchodilators if being given concurrently. |
|
Combination Inhalers:
|
Advair: combines Flovent with Serevent
Combivent: combines albuterol with Atrovent |
|
ORAL STEROID:
|
PREDNISONE
Methylprednisolone (Medrol) Dexamethasone (Decadron) |
|
ORAL STEROID:
Action |
Potent antiinflammatory has glucocorticoid and mineralcorticoid effects.
|
|
ORAL STEROID:
Indications |
Severe Inflammation, Allergic Reactions, Bronchospasms.
|
|
ORAL STEROID:
Important A/E |
Psychosis, Edema, Fluid Retention, Hyperglycemia, Immunosupression, Hypokalemia, GI Bleed, Poor Wound Healing, GI Distress.
|
|
ORAL STEROID:
Notes |
-Abrupt Withdrawal causes rebound inflammation and can be fatal.
-Administer with food or milk. |
|
DIURETICS:
THIAZIDES |
Hydrochlorithiazide (HCTZ) etc.
|
|
DIURETICS:
THIAZIDES Action |
Inhibits sodium reabsorption in the distal renal tubule.
|
|
DIURETICS:
THIAZIDES Indications |
HTN, Edema
|
|
DIURETICS:
THIAZIDES Important A/E |
Hypotension, hypokalemia, hyponatremia hyperglycemia, volume depletion, gout.
|
|
LOOP DIURETICS
|
Bumetandine (Bumex)
Furosemide (Lasix) |
|
LOOP DIURETICS
Indications |
Renal Failure, CHF, HTN.
|
|
LOOP DIURETICS
Action |
More potent than thiazide. Inhibits sodium reabsorption in renal tubule at loop of henle.
|
|
LOOP DIURETICS
Important A/E |
Blood Dyscrasias, Volume Depletion, Orthostatic Hypotension, Hypokalemia, hyponatremia Hyperglycemia.
|
|
POTASSIUM SPARING DIURETICS
|
Spironolacane (Aldactone)
Triamterene (Dyenium) |
|
POTASSIUM SPARING DIURETICS
Indications |
Edema, HTN, CHF.
|
|
POTASSIUM SPARING DIURETICS
Action |
Inhibits distal convoluted tubule aldosterone receptors
|
|
POTASSIUM SPARING DIURETICS
Important A/E |
Hyperkalemia, Headache, Anorexia, Dehydration, Elevated BUN, Acidosis, Hypotension.
|
|
DIURETICS
COMBINATION PRODUCTS: |
DYAZIDE (Triamterene 50mg and HCTZ 25mg)
MAXZIDE (Triamterene 75mg and HCTZ 50mg) Given to minimize potassium imbalances caused by other diuretics. |
|
H2 BLOCKERS:
|
Cimetidine (Tagamet)
Famotidine (Pepcid) Nizatidine (Axid) Ranitidine (Zantac) |
|
H2 BLOCKERS:
Indications |
Douodenal Ulcers, Esophagitis and esophageal reflux.
|
|
H2 BLOCKERS:
Action |
Blocks H2 receptors
|
|
H2 BLOCKERS:
Important A/E |
Blood Dyscrasias, diarrhea, nausea, constipation.
|
|
H2 BLOCKERS:
Notes: |
Tagamet has more interactions with other drugs than the other H2 blockers.
|
|
Proton Pump Inhibitors (PPIs):
|
Omeprazole (Prilosec)
Lansoprazole (Prevacid) Pantoprazole (protonix) Esomeprazole (Nexium) Rabeprazole (Aciphex) |
|
Proton Pump Inhibitors (PPIs):
Indications |
Esophagitis, Gastroesophogeal reflux disease, Duodenal Ulcer
|
|
Proton Pump Inhibitors (PPIs):
Action |
Inhibits gastric parietal cell proton pump
|
|
Proton Pump Inhibitors (PPIs):
Important A/E |
headache, dizziness, cough, nausea, vomiting, constipation, flatulence
|
|
Proton Pump Inhibitors (PPIs):
Notes: |
-Can increase serum levels of diazepam, phenytoin and coumadin monitor closely.
|
|
ORAL HYPOGLYCEMICS:
|
Chlorpromide (Diabinese)
Glipizide (Glucotrol) Glyburide (Diabeta, Micronase) Glimepiride (Amaryl) |
|
ORAL HYPOGLYCEMICS:
Indications |
Glucose Control in Type II Diabetes Mellitus.
|
|
ORAL HYPOGLYCEMICS:
Action |
Stimulate beta cell activity in the pancreas
|
|
ORAL HYPOGLYCEMICS:
Important A/E |
Hypoglycemia, dizziness, jaundice.
|
|
ORAL HYPOGLYCEMICS:
Notes: |
-Monitor Blood Glucose if indicated.
-Look for symptoms of hypoglycemia. -Educate patient about his disease, diet and management of hypoglycemic episodes. |
|
TZDs
|
Rosiglitazone(Avandia)
Pioglitazone (Actos) |
|
TZDs
Indications |
Adjunct to diet and insulin control of Type II diabetes.
|
|
TZDs
Action |
Insulin sensitizer.
|
|
TZDs
Important A/E |
Headache, peripheral edema, elevated liver enzymes, nausea, diarrhea, hypoglycemia when used in conjunction with insulin.
|
|
TZDs
Notes: |
-monitor liver enzymes,
-monitor blood glucose for response/ hypoglycemia. Contraindicated in CHF |
|
Metformin (Glucophage)
Indication |
Adjunctive control of blood glucose in Type 2 diabetes.
|
|
Metformin (Glucophage)
Action |
Decreased hepatic glucose production and insulin sensitizer.
|
|
Metformin (Glucophage)
A/E |
diarrhea, nausea, vomiting, bloating, lactic acidosis, megablastic anemia
|
|
Metformin (Glucophage)
Notes: |
Contraindicated for patients with impaired renal function (increased risk of lactic acidosis) Hold when patient dehydrated or receives contrast dyes.
|
|
THYROID SUPPLEMENTS:
|
Levothyroxine (Synthroid) (Levoxyl)
Thyroid Dessicated (Armour Thyroid) |
|
THYROID SUPPLEMENTS:
Indication |
Hypothyroidism
|
|
THYROID SUPPLEMENTS:
Action |
Thyroid hormone replacement
|
|
THYROID SUPPLEMENTS:
Important A/E |
Toxicity as evidenced by nervousness, insomnia, tachycardia, arrhythmias, angina, HTN, heat intolerance.
|
|
THYROID SUPPLEMENTS:
Notes: |
-Monitor TSH and other thyroid values.
|
|
WARFARIN SODIUM (COUMADIN):
Indications |
Prevention of thrombus formation.
|
|
WARFARIN SODIUM (COUMADIN):
Action |
Inhibits production of Vitamin K dependent clotting factors.
|
|
WARFARIN SODIUM (COUMADIN):
Important A/E |
Hemorrhage, GI Bleed, Bruises, Anemia secondary to bleeding.
|
|
WARFARIN SODIUM (COUMADIN):
Notes: |
-Monitor Protime/INR closely.
-Vitamin K is an antidote to Coumadin. -Avoid Concurrent administration of ASA or NSAIDS. - Educate patient about risks and precautions associated with drug. |
|
Clopidogrel (Plavix):
Indications |
Cardiovascular prophylaxis by decreased platelet aggregation
|
|
Clopidogrel (Plavix):
A/E |
hemorrhage, edema, and ulcer
|
|
Clopidogrel (Plavix):
Notes |
Use caution with NSAIDS, ASA or coumadin due to increased risk of bleeding or ulcer
|
|
Heparin (Unfractionated)
Fondaparinux (Arixtra) (low molecular weight heparin) Enoxaparin (Lovenox) (low molecular weight heparin) Indications |
Prevention or treatment of DVT or thromboembolism
|
|
Heparin (Unfractionated)
Fondaparinux (Arixtra) (low molecular weight heparin) Enoxaparin (Lovenox) (low molecular weight heparin) Action |
Inhibits thrombin and conversion of fibrinogen to fibrin
|
|
Heparin (Unfractionated)
Fondaparinux (Arixtra) (low molecular weight heparin) Enoxaparin (Lovenox) (low molecular weight heparin) A/E |
Bleeding/hemorrhage
|
|
Heparin (Unfractionated)
Fondaparinux (Arixtra) (low molecular weight heparin) Enoxaparin (Lovenox) (low molecular weight heparin) Notes |
Monitor platelet count and PTT for heparin. Lab monitoring not required for low molecular weight heparins after initiation. Do not aspirate or rub subcutaneous injection.
|
|
CARBIDOPA/LEVODOPA (SINEMET):
Indications |
Parkinson's
|
|
CARBIDOPA/LEVODOPA (SINEMET):
Actions |
Increases CNS availability of Dopamine
|
|
CARBIDOPA/LEVODOPA (SINEMET):
Important A/E |
Nervousness, Hemolytic Anemia, Delirium, Hallucinations, Ataxia, Orthostatic Hypotension, Nausea and Vomiting, anorexia, Urinary Retention.
|
|
Entacapone (Comtan)
Indication |
Adjunctive to Sinemet for Parkinsons
|
|
Entacapone (Comtan)
Action |
Decreases peripheral metabolism of Sinemet increases amount available to CNS.
|
|
Entacapone (Comtan)
Important A/E |
Dyskinesias, Hypotension, Diarrhea, Hallucinations, and Syncope
|
|
Stalevo:
|
Combination of Sinemet and Comtan
|
|
Acetocholinesterase Inhibitors
|
Donzepezil (Aricept)
Rivastigmine (Exelon) Galantamine (Reminyl) |
|
Acetocholinesterase Inhibitors
Indication |
Mild to moderate dementia of the Alzheimer's Type.
|
|
Acetocholinesterase Inhibitors
Action |
Inactivates acetocholinesterase an enzyme that breaks down acetylcholine.
|
|
Acetocholinesterase Inhibitors
Important A/E |
Headache, insomnia, dizziness, depression, vertigo, ataxia, aphasia, syncope, HTN, hypotension, atrial fib, cataracts, blurred vision, nausea, diarrhea, vomiting, fecal incontinence, weight loss.
|
|
Memantine (Namenda)
Indication |
Alzheimer’s
|
|
Memantine (Namenda)
Action |
Decreases NMDA an excitatory neurotransmitter
|
|
Memantine (Namenda)
Important A/E |
Somnolence, Hallucinations, Fatigue, Nausea, Vomiting, and Constipation
|
|
Narcotics
|
Morphine
Hydromorphone (Dilaudid) Meperidine (Demerol) Codeine Oxycodone Oxycodone with Acetominophen (Percocet) Hydrocodone with Acetominphen (Vicodin) Long acting Oxycodone (Oxycontin) Fentanyl (Duragesic) |
|
Narcotics
Indications |
Moderate to severe pain
|
|
Narcotics
Actions |
Binds to opiate receptors
|
|
Narcotics
Important A/E |
Respiratory Depression, Sedation, Nausea/Vomiting, and Constipation
|
|
Narcotics
Notes |
Give oral forms with food. Titrate to pain levels. Monitor bowel function. Administer Laxative as ordered for patient using more than 1-2 days. Long-term use will result in withdrawal symptoms if stopped abruptly.
|